Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Cash from Financing Activities (2018 - 2025)

Avai Bio's Cash from Financing Activities history spans 6 years, with the latest figure at $135907.0 for Q1 2024.

  • On a quarterly basis, Cash from Financing Activities fell 16.19% to $135907.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $1.4 million, a 741.27% increase, with the full-year FY2025 number at $1.2 million, down 9.0% from a year prior.
  • Cash from Financing Activities hit $135907.0 in Q1 2024 for Avai Bio, down from $705085.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for AVAI hit a ceiling of $705085.0 in Q4 2023 and a floor of -$55248.0 in Q3 2022.
  • Historically, Cash from Financing Activities has averaged $152917.6 across 4 years, with a median of $87341.0 in 2022.
  • Biggest five-year swings in Cash from Financing Activities: crashed 320.86% in 2020 and later skyrocketed 4091.42% in 2023.
  • Tracing AVAI's Cash from Financing Activities over 4 years: stood at -$13296.0 in 2020, then crashed by 32.86% to -$17665.0 in 2022, then skyrocketed by 4091.42% to $705085.0 in 2023, then tumbled by 80.72% to $135907.0 in 2024.
  • Business Quant data shows Cash from Financing Activities for AVAI at $135907.0 in Q1 2024, $705085.0 in Q4 2023, and $421363.0 in Q3 2023.